Novel Therapeutic Targets and Management in Pediatric Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 20 December 2024 | Viewed by 567
Special Issue Editor
Interests: pediatric brain tumor; ewing-sarcoma; neuroblastoma; ATRT; glioma; predisposition syndrome
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The treatment of pediatric malignancies has reached a milestone in recent years. The wide use of modern diagnostic methods provides a deeper insight into the molecular background of pediatric solid tumors and leukemias, which facilitates a better prognostic estimation for individual tumors and also enables the use of targeted therapy in certain cases. The introduction of treatment modalities applying immunological aspects of leukemias and solid tumor provides the long-term control of tumor growth and a better survival. Newer approaches of targeted and immunotherapy will hopefully fundamentally change the treatment of pediatric malignancies by the marginalization of conventional chemotherapy with an increased burden of long-term side effects. The application of modern molecular technics may promote the early recognition of predisposition syndromes, patients then undergoing a subsequent regular follow-up, helping an early diagnosis and better survival of pediatric malignancies in certain cases.
This Special Issue aims to provide an overview of the recent advances in predisposition syndromes, targeted treatment, and immunotherapy in the field of pediatric hematology and oncology.
Dr. Péter Hauser
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatric tumor
- pediatric brain tumor
- bone tumor
- neuroblastoma
- targeted treatment
- immunotherapy
- predisposition syndrome
